Is ZTS Worth Buying in 2026?

ZOETIS INC.

STOCK PHARMACEUTICAL PREPARATIONS Updated 2026-06-07

Here’s whether ZOETIS INC. (ZTS) is worth buying in 2026 — based on weekly-updated price trend, RSI momentum, and return vs. the S&P 500. Our current read: Bearish.

🔴
Bearish

Concerns: trading below the 200-day MA (long-term downtrend); below the 50-day MA (medium-term momentum negative); 50-day MA is falling (-7.00% over 10 days); weak 1-year return of -52.9%; 3-month momentum negative (-35.1%). Currently 53.7% off its 52-week high. Score: -6/7.

Ready to act on this? 📈 Trade on Webull

ZTS is trading below its 200-day MA ($124.12) — a key warning sign the longer-term trend is under pressure. An RSI of 67.1 sits in the neutral zone — momentum is neither stretched nor exhausted. The 1-year return of -52.9% compares to +24.4% for SPY (trailed the market by 77.3%). The current 53.7% drawdown from the 52-week high reflects elevated risk for momentum-based strategies.

$10,000 invested 1 year ago → $4,711 today
vs. S&P 500 (SPY) — same period trailed market by 77.3%

1-Year Price Chart

Daily candles
MA-50 MA-200 Up Down

Signal Check

Above 200-day MA ($124.12)
Above 50-day MA ($101.06)
RSI(14) neutral zone (30–70) — currently 67.1
Positive return (-52.9%)
!Within 10% of period high (−53.7%)
Period Range $79.44
$72.38 $171.52
RSI (14) 67.1
0 · OversoldOverbought · 100

Key Metrics

Price$79.44
Period Return-52.9%
Period High$171.52
Period Low$72.38
Drawdown−53.7%
MA-50$101.06
MA-200$124.12
RSI (14)67.1
Avg Volume (30d)8.2M
vs. SPYtrailed by 77.3%
Return Rank#1097 of 1245

Trade ZTS

📈 Trade on Webull 📊 Trade on moomoo 💹 Interactive Brokers